tiprankstipranks
Trending News
More News >
Niva Bupa Health Insurance Company Limited (IN:NIVABUPA)
:NIVABUPA
India Market
Advertisement

Niva Bupa Health Insurance Company Limited (NIVABUPA) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

NIVABUPA Financial Forecast

NIVABUPA Earnings Forecast

Next quarter’s earnings estimate for NIVABUPA is -₹0.38 with a range of -₹0.38 to -₹0.38. The previous quarter’s EPS was ₹1.13. NIVABUPA beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.99% of the time in the same period. In the last calendar year NIVABUPA has Outperformed its overall industry.
Next quarter’s earnings estimate for NIVABUPA is -₹0.38 with a range of -₹0.38 to -₹0.38. The previous quarter’s EPS was ₹1.13. NIVABUPA beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.99% of the time in the same period. In the last calendar year NIVABUPA has Outperformed its overall industry.

NIVABUPA Sales Forecast

Next quarter’s sales forecast for NIVABUPA is ₹14.97B with a range of ₹12.78B to ₹16.11B. The previous quarter’s sales results were ₹13.75B. NIVABUPA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.45% of the time in the same period. In the last calendar year NIVABUPA has Preformed in-line its overall industry.
Next quarter’s sales forecast for NIVABUPA is ₹14.97B with a range of ₹12.78B to ₹16.11B. The previous quarter’s sales results were ₹13.75B. NIVABUPA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.45% of the time in the same period. In the last calendar year NIVABUPA has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on IN:NIVABUPA
Subramanian IyerMorgan Stanley
Morgan Stanley
₹88₹76
Hold
-12.48%
Downside
Reiterated
03/12/25
Niva Bupa Health Insurance (NIVABUPA:IN) PT Lowered to INR76 at Morgan StanleyMorgan Stanley analyst Subramanian Iyer lowered the price target on Niva Bupa Health Insurance (NIVABUPA:IN) to INR76.00 (from INR88.00) while maintaining a Equalweight rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on IN:NIVABUPA
Subramanian IyerMorgan Stanley
Morgan Stanley
₹88₹76
Hold
-12.48%
Downside
Reiterated
03/12/25
Niva Bupa Health Insurance (NIVABUPA:IN) PT Lowered to INR76 at Morgan StanleyMorgan Stanley analyst Subramanian Iyer lowered the price target on Niva Bupa Health Insurance (NIVABUPA:IN) to INR76.00 (from INR88.00) while maintaining a Equalweight rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

NIVABUPA Analyst Recommendation Trends

Rating
Mar 25
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
total
1
In the current month, NIVABUPA has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. NIVABUPA average Analyst price target in the past 3 months is 76.00.
Each month's total comprises the sum of three months' worth of ratings.

NIVABUPA Stock Forecast FAQ

What is IN:NIVABUPA’s average 12-month price target, according to analysts?
Based on analyst ratings, Niva Bupa Health Insurance Company Limited’s 12-month average price target is 76.00.
    What is IN:NIVABUPA’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for IN:NIVABUPA, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Niva Bupa Health Insurance Company Limited a Buy, Sell or Hold?
        Niva Bupa Health Insurance Company Limited has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Niva Bupa Health Insurance Company Limited’s share price target?
          The average share price target for Niva Bupa Health Insurance Company Limited is 76.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is ₹76.00 ,and the lowest forecast is ₹76.00. The average share price target represents -12.48% Decrease from the current price of ₹86.84.
            What do analysts say about Niva Bupa Health Insurance Company Limited?
            Niva Bupa Health Insurance Company Limited’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of Niva Bupa Health Insurance Company Limited?
              To buy shares of IN:NIVABUPA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis